NRX Pharmaceuticals Inc (STU:B1Q)
€ 4.88 0 (0%) Market Cap: 42.04 Mil Enterprise Value: 46.28 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 29/100

Q4 2023 NRX Pharmaceuticals Inc Earnings Call Transcript

Apr 01, 2024 / 12:30PM GMT
Operator

Good morning, everyone, and welcome to the NRx Pharmaceuticals, Inc fourth quarter and full year 2023 results conference call. Currently, all participants are in a listen only mode as a reminder, this conference call is being recorded. I will now turn the call over to Matthew Duffy, the company's Chief Business Officer. Please go ahead.

Matthew Duffy
NRX Pharmaceuticals Inc - Chief Business Officer

Thank you, Camilla, and welcome, everyone.

Before we proceed with the call.

I would like to remind everyone that certain statements made during this call are forward-looking statements under U.S. federal securities laws. These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectations. Additional information concerning factors that could cause actual results to differ from statements made on this call is contained in our periodic reports filed with the SEC. Forward-looking statements made during this call speak only as of the date hereof, and the company

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot